Technical Analysis for PAA - PharmAust Limited  

Grade Last Price % Change Price Change
D 0.180 -5.26% -0.010
PAA closed down 5.26 percent on Wednesday, May 15, 2024, on 66 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down

Date Alert Name Type % Chg
180 Bearish Setup Bearish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction -5.26%
Wide Bands Range Expansion -5.26%
Oversold Stochastic Weakness -5.26%
NR7 Range Contraction 2.86%
Narrow Range Bar Range Contraction 2.86%
Wide Bands Range Expansion 2.86%
Oversold Stochastic Weakness 2.86%

   Recent Intraday Alerts

Alert Time
Down 2% about 20 hours ago
Down 1% about 20 hours ago
Rose Above Previous Day's High about 22 hours ago
Up 2% about 22 hours ago
Up 1% about 22 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

PharmAust Limited   Description

Pharmaust Limited is a drug discovery and development company. The principal activities of the Company are to develop its own drug discovery intellectual property, namely approximately three platforms for the treatment of different types of cancers in humans and animals, as well as providing specialized medicinal and synthetic chemistry services on a contract basis to clients. The Company's segments are Corporate and Pharmaceutical. The Pharmaceutical segment provides products and services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries. The Corporate segment covers all the corporate overhead expenses. Its subsidiaries include Pitney Pharmaceuticals Pty Ltd, which is engaged in business of developing therapeutic cancer products, and Epichem Pty Ltd, which offers a range of rare and hard to find pharmaceutical impurities, degradants and metabolites of active ingredients and excipients, particularly for over-the-counter and generic drugs.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Chemistry Health Pharmaceutical Cancer Drugs Pharmaceuticals Intellectual Property Cancers Pharmacy Health Sciences Pharmaceutical Industry Drug Discovery Pharmaceuticals Policy Animals Medication Pharmaceutical Industry In China Science And Technology In The People's Republic Of China Humans Pharmaceutical Sciences Generic Drug Medicinal Chemistry Pharmaceutical Industries

Is PAA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.535
52 Week Low 0.065
Average Volume 1,478,967
200-Day Moving Average 0.156
50-Day Moving Average 0.302
20-Day Moving Average 0.244
10-Day Moving Average 0.201
Average True Range 0.023
RSI (14) 29.58
ADX 41.44
+DI 15.121
-DI 38.227
Chandelier Exit (Long, 3 ATRs) 0.297
Chandelier Exit (Short, 3 ATRs) 0.231
Upper Bollinger Bands 0.345
Lower Bollinger Band 0.142
Percent B (%b) 0.19
BandWidth 83.203
MACD Line -0.038
MACD Signal Line -0.032
MACD Histogram -0.0062
Fundamentals Value
Market Cap 56.92 Million
Num Shares 316 Million
EPS -0.01
Price-to-Earnings (P/E) Ratio -25.71
Price-to-Sales 11.12
Price-to-Book 4.45
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.203
Resistance 3 (R3) 0.205 0.200 0.199
Resistance 2 (R2) 0.200 0.194 0.199 0.197
Resistance 1 (R1) 0.190 0.191 0.188 0.188 0.196
Pivot Point 0.185 0.185 0.184 0.184 0.185
Support 1 (S1) 0.175 0.179 0.173 0.173 0.164
Support 2 (S2) 0.170 0.176 0.169 0.163
Support 3 (S3) 0.160 0.170 0.161
Support 4 (S4) 0.158